Companies / Catamaran Bio
Catamaran Bio
Company
Catamaran Bio engineers NK cell therapies to provide treatments for solid tumors and other cancers.
Catamaran Bio has 2 investors on file, among them Astellas Venture Management and Sofinnova Partners. Its site was last checked 12 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC | |
| Portfolio page | Venture capital |
More from Astellas Venture Management
24 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Astellas Venture Management's full profile · Who invests alongside it
More from Sofinnova Partners
111 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (69%), AI & Machine Learning (13%), Food & Agriculture (4%).
See Sofinnova Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Catamaran Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Astellas Venture Management adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/catamaranbio.com/investors
# also
GET /v1/companies/catamaranbio.com
GET /v1/companies/catamaranbio.com/news